Cargando…
P1225: CYLD, A NOVEL REGULATOR OF SPLENIC MARGINAL ZONE LYMPHOMA PATHOGENESIS
Autores principales: | Pseftogkas, Athanasios, Bordini, Jessica, Frenquelli, Michela, Bonfiglio, Ferdinando, Daibata, Masanori, Ángel Martínez-Climent, José, Mosialos, George, Rossi, Davide, Campanella, Alessandro, Xanthopoulos, Konstantinos, Ghia, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431029/ http://dx.doi.org/10.1097/01.HS9.0000971792.11771.06 |
Ejemplares similares
-
P1222: ANTIGEN-INDEPENDENT, CELL-AUTONOMOUS SIGNALING IN SPLENIC MARGINAL ZONE LYMPHOMA
por: Iatrou, Anastasia, et al.
Publicado: (2023) -
Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
por: Bekas, Nikolaos, et al.
Publicado: (2023) -
Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma
por: Higuchi, Tomonori, et al.
Publicado: (2017) -
Truncation of the Deubiquitinating Domain of CYLD in Myelomonocytic Cells Attenuates Inflammatory Responses
por: Tsagaratou, Ageliki, et al.
Publicado: (2011) -
The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGFβ Signaling
por: Pseftogas, Athanasios, et al.
Publicado: (2020)